Pharmafile Logo
Pharmafocus logo
Advanced Search

Eisai launches cancer drug Halaven in UK

April 20, 2011
Sales and Marketing Eisai, Halaven, breast cancer

Eisai’s sea sponge derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a …

News

Novavax appoints Stanley Erck chief executive

April 20, 2011
Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …

Appointment

Generics push US drug growth to $307bn

April 20, 2011
IMS, IMS Health, drug spending, healthcare spending

Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …

News

Warner Chilcott plans to axe 500 jobs in Europe

April 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts

Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …

News

Contract research news in brief

April 20, 2011
Research and Development CRO, contract research

Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …

News

Life Healthcare Communications expands

April 20, 2011
Medical Communications appointment, medical communications

Life Healthcare Communications has expanded, adding new employees and extending its existing digital department.The Berkshire, UK-based creative communications agency has …

News

Circassia raises funds to develop allergy products

April 19, 2011
Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

News
Novartis Gilenya (fingolimod)

Oral MS drug Gilenya launched in the UK

April 19, 2011
Sales and Marketing Novartis, gilenya, multiple sclerosis

Gilenya has become the first oral multiple sclerosis drug to be launched in the UK. Gilenya (fingolimod) is licenced to …

News
Novartis' Afinitor (everolimus)

NICE unimpressed with Novartis’ patient access scheme

April 19, 2011
Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis

Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …

News

FDA issues guidance on preventing antibiotic cross-contamination

April 19, 2011
Manufacturing and Production FDA, GMP, pharma manufacturing

The FDA has published a new guidance document to help drugmakers prevent cross-contamination of pharmaceuticals with non-penicillin beta-lactam antibiotics. The …

News

Organogenesis to build ‘largest automated living cell facility’

April 19, 2011
Manufacturing and Production Cell biology, Organogenesis, pharma manufacturing

Regenerative medicine specialist Organogenesis has started construction of an automated manufacturing facility for human cells, which it claims will be …

News
Arthritis drug Remicade

J&J and Merck reach compromise on arthritis drug rights

April 19, 2011
Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi

Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …

News

GlaxoSmithKline OTC sale puts two plants on the block

April 19, 2011
Manufacturing and Production GSK, US, pharma manufacturing

GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …

News
Boehringer Ingelheim

Boehringer’s Pradaxa recommended for expanded European licence

April 18, 2011
Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa

Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …

News
knowledgepoint360_interphase_tim_mustill

Tim Mustill and Jenny Hepburn join InterPhase

April 18, 2011
Sales and Marketing appointment, sales and marketing

KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase. Tim has …

Appointment
Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …

News

TBA contamination prompts Topamax recall

April 18, 2011
Manufacturing and Production Johnson and Johnson, recalls

Another Johnson & Johnson business unit has decided to recall medicines because of a mouldy smell thought to be caused …

News

VBP: a fait accompli or room for manoeuvre?

April 18, 2011
Sales and Marketing value-based pricing

The pharma industry is seeking a compromise on the UK’s proposed value- based pricing, which promises to revolutionise the country’s …

Feature
Genzyme's headquarters

Genzyme MS drug shines in head-to-head trial with Rebif

April 18, 2011
Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …

News

Fishawack gains industry experts

April 15, 2011
Medical Communications Fishawhack, PR

The Fishawack Group has gained industry experts Linda Harris and Jo Jarvis to expand its stakeholder relations and thought leader …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026